University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors

Simple item page
dc.contributor.authorMark, Patrick B.
dc.contributor.authorPapworth, Richard
dc.contributor.authorRamparsad, Nitish
dc.contributor.authorTomlinson, Laurie
dc.contributor.authorSawhney, Simon
dc.contributor.authorBlack, Corri
dc.contributor.authorMcConnachie, Alex
dc.contributor.authorMcCowan, Colin
dc.contributor.institutionUniversity of Aberdeen.Farr Aberdeenen
dc.contributor.institutionUniversity of Aberdeen.Chronic Disease Research Groupen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Health Data Scienceen
dc.date.accessioned2021-01-03T00:09:50Z
dc.date.available2021-01-03T00:09:50Z
dc.date.embargoedUntil2021-01-03
dc.date.issued2020-01
dc.descriptionAcknowledgments: The authors would like to thank Claire MacDonald from NHS Greater Glasgow and Clyde Safe Haven for technical assistance with the project. Funding: This work was funded by the Chief Scientist Office Scotland (grant HICG/1/1)en
dc.description.statusPeer revieweden
dc.format.extent11
dc.format.extent1442127
dc.identifier149495785
dc.identifier4740496a-feaa-41d2-b0a0-48fadcb9f63e
dc.identifier31663151
dc.identifier000505362400001
dc.identifier85078035119
dc.identifier.citationMark, P B, Papworth, R, Ramparsad, N, Tomlinson, L, Sawhney, S, Black, C, McConnachie, A & McCowan, C 2020, 'Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors', British Journal of Clinical Pharmacology, vol. 86, no. 1, pp. 121-131. https://doi.org/10.1111/bcp.14141en
dc.identifier.doi10.1111/bcp.14141
dc.identifier.iss1en
dc.identifier.issn0306-5251
dc.identifier.otherORCID: /0000-0002-7960-4573/work/97666997
dc.identifier.urihttps://hdl.handle.net/2164/15578
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85078035119&partnerID=8YFLogxKen
dc.identifier.vol86en
dc.language.isoeng
dc.relation.ispartofBritish Journal of Clinical Pharmacologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectacute kidney injuryen
dc.subjectangiotensin converting enzyme inhibitoren
dc.subjectangiotensin receptor blockeren
dc.subjectheart failureen
dc.subjectchronic kidney diseaseen
dc.subjectMORTALITYen
dc.subjectSURVIVALen
dc.subjectMANAGEMENTen
dc.subjectHEART-FAILUREen
dc.subjectINCREASESen
dc.subjectMORBIDITYen
dc.subjectNONSTEROIDAL ANTIINFLAMMATORY DRUGSen
dc.subjectCLINICAL-PRACTICE GUIDELINEen
dc.subjectOUTCOMESen
dc.subjectDIURETICSen
dc.subjectR Medicine (General)en
dc.subjectPharmacology (medical)en
dc.subjectPharmacologyen
dc.subjectChief Scientist Office (CSO)en
dc.subjectHICG/1/1en
dc.subject.lccR1en
dc.titleRisk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitorsen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Mark_et_al_2019_British_Journal_of_Clinical_Pharmacology_AAM.pdf
Size:
1.38 MB
Format:
Adobe Portable Document Format
Download

Collections

All research